Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

MTS selects Ericsson to prepare network for 5G and IoT

· MTS to upgrade its network with Ericsson Radio System and core network solutions to prepare for 5G and IoT · The agreement includes 5G- and IoT-ready hardware and software for the next three years · Deployment starts Q4 2017 and total contract value exceeds EUR 400 millionEricsson (NASDAQ: ERIC) and MTS (NYSE: MBT), the largest telecommunications operator in Russia, have agreed to upgrade the network of MTS. Ericsson will deliver the newest software features that will be continuously developed during the next three years. The scope of the agreement also includes 5G-ready radio

Humana grows in Finland

Humana AB, a leading Nordic care company, acquires Ryhmäkoti Raide Oy (Raide Oy) with residential care home operations for children and youth in Tampere area, Finland. The acquisition entails a geographic expansion and strengthens our service offering.Humana AB has entered an agreement to acquire all shares in Ryhmäkoti Raide Oy (Raide). The transfer will take place immediately and the operations of Raide Oy will be included in Arjessa, Humana’s Finnish subsidiary. Ryhmäkoti Raide Oy is currently operating a specialised treatment unit for children and youth in Tampere area. Revenues in

Apply for the Swedish Steel Prize 2018 – and blow our minds

The time has come once again and the Swedish Steel Prize 2018 is now accepting applications. So, have you developed a unique and groundbreaking steel product or do you have a solution that will impact positively on your business? How about a process or method that will take us all to the next level? If the answer to any of these is yes, then we want to hear from you. And this year, we really want you to blow our minds. For nearly 20 years, the Swedish Steel Prize has been an icon within the steel industry. It has recognized and rewarded small and large companies, as well as

Monobank ASA: MONO-ME - Completion of private placement

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES Bergen, 23 October 2017   Completion of private placement and intention to apply for full listing within the next 12 months Reference is made to the stock exchange announcement published 18 October 2017 regarding a private placement (the "Private Placement") in Monobank ASA ("Monobank" or the "Company"). The Company announces that the board of directors (the "Board") has resolved to complete the Private Placement with gross proceeds of NOK

NPRO: CONTEMPLATING NOK BOND ISSUANCE

Norwegian Property ASA has mandated Nordea and SEB to investigate the opportunity to issue new bonds in the Norwegian bond market. Subject to market conditions, one or several NOK senior secured bonds issues with tenors in the range 3-7 years may follow. For further information, please contact:Ane Grimsmo, Finance Manager, tel +47 938 73 885 This information is subject to disclosure requirements pursuant to §5-12 of the Norwegian Securities Trading Act.

Comparative Investigation of TetraGraph and TOF-Watch SX

Press release Uppsala, 23 October 2017. Dr Réka Nemes at the University of Debrecen, Department of Anesthesiology and Intensive Care, Debrecen, Hungary, reports results from the Comparative Investigation of TetraGraph and TOF-Watch SX.The results will be presented at the American Society of Anesthesiologists (ASA) Annual Meeting in Boston, USA. For more than 67 years, the ASA annual meeting has been the most comprehensive anesthesia-related educational event in the world, bringing together top influential and notable professionals in anesthesiology, pain medicine and critical care

Tieto announces a recommended public offer for Avega, a Swedish consulting company

Tieto Corporation        Stock Exchange Release     23 October 2017        9.45 EET This press release may not be published or otherwise distributed, in whole or in part, in or into, directly or indirectly, Australia, Hong Kong, Japan, Canada, New Zeeland, South Africa or the USA, or any other jurisdiction where making the public offer or the distribution of this press release would be in conflict with any applicable law or regulation or would require any additional offer documents or registrations or other measures in addition to those required by Swedish law. Tieto announces a

Presentation of Probi’s Q3 report 2017

Probi’s report for the third quarter 2017 will be published on Wednesday, 25 October at 8.00 a.m. CET In conjunction with this, analysts, investors and media are invited to an audiocast telephone conference on the same day at 10.00 a.m., where CEO Peter Nählstedt and CFO Jörn Andreas will present and comment on the report. The presentation and presentation material can be obtained via www.probi.se or https://tv.streamfabriken.com/probi-q3-2017 The presentation can also be followed via a telephone conference on the following telephone number:Sweden: +46 8 50 33 65 62UK: +44 20 33

Cargonet gains robust technology platform at EVRY’s new cloud centre

EVRY has successfully completed the migration of Cargonet’s infrastructure to EVRY’s cloud centre. This modernisation of Cargonet’s technology gives it strong foundations, and in the time ahead the company will be able to accelerate its transition to modern cloud solutions.Cargonet is Norway’s largest transporter of goods by rail, and its activities run day and night. Over three weekends the transport company’s entire technology infrastructure and core applications were migrated to EVRY’s new cloud centre in Fet without any adverse incidents or impact on its operational services.

Oncology Venture Updates on Pipeline and Business

Hoersholm, Denmark -- October 23rd  2017 – Oncology Venture Sweden AB:s (OV:ST) (“Oncology Venture” or “OV”) announces a pipeline and business update: Oncology Venture has within the last six months signed agreements for two product candidates – a PARP/tankyrase inhibitor from Eisai and a tyrosine kinase inhibitor (TKI) from Novartis. We know thar there is fierce competition to acquire these types of assets, and we believe that the  the differentiated DRP™ companion diagnostic technology enabled us to secure these high profiled products licenses. Accordingly these two new products will be of

Nominating committee appointed at NetEnt AB (publ) ahead of AGM 2018

In accordance with the decision by the Annual General Meeting, the members of the nominating committee of NetEnt should be appointed by the three shareholders/owner groups controlling the largest number of votes in NetEnt at the end of August, which desire to appoint a representative. In addition, the Chairman of the Board of Directors shall be a member of the nominating Committee. NetEnt hereby announces that the nominating committee has been appointed ahead of the Annual General Meeting in April 2018. The nomination committee consists of the following members:• John Wattin, Chairman (

Data on the clinical activity of simeprevir in combination with AL-335 and odalasvir (JNJ-4178) presented at the 2017 Liver Meeting™

Stockholm, Sweden - Medivir AB (Nasdaq Stockholm: MVIR) today communicates phase IIb data on JNJ-4178, the triple combination consisting of simeprevir, odalasvir and AL-335, following presentations at the 2017 Liver Meeting™ organized by the American Association for the Study Liver Diseases (AASLD) and held in Washington DC on 20-24 October. SVR12 data from OMEGA-1, a global open-label phase IIb study of the efficacy and safety of JNJ-4178 in non-cirrhotic patients with HCV genotypes 1, 2, 4, 5 and 6, were presented at the conference. The results showed that 98.9% (181/183) of patients

WeSC signs new license agreement for WeSC underwear, socks and sleepwear in North America

Stockholm, Sweden, October 23, 2017WeSC signed a new agreement for underwear, socks and sleepwear with Versa Textiles. This agreement assures a continuing positive development of the business in North America. The WeSC brand continues to resonate in North America despite a difficult retail market with a new kid's licenses signed earlier this month and addition interest for more collaborations and licensing opportunities. “We are excited about taking steps that enable continued growth in North America in several product groups. We have already received positive indications from our

INVISIO: Invitation to Q3 2017 conference call on October 30 at 14.00 CET

Stockholm, October 23, 2017 INVISIO is pleased to invite press, investors and analysts to a conference call on October 30 at 14.00 CET where CEO Lars Højgård Hansen and CFO Thomas Larsson present the INVISIO 2017 January–September interim report.The conference call, which will be held in English, will begin with a presentation of the interim results followed by a Q&A session.The interim report will be published the same day at 8.30 a.m.Phone number for the conference:To participate in the conference call, use the dial-in numbers below. Please dial in 5-10 minutes prior to the

Stillfront Group AB: War and Peace: Civil War in Global Launch

PRESS RELEASE     Oct 23, 2017   eRepublik Labs, one of Stillfront Group's studios, has launched its third historical strategy MMO, "War and Peace: Civil War" on Google Play and the App Store Thursday Oct 19, 2017. The game, an eRepublik Labs owned IP and trademark, received worldwide featuring from Google Play for its launch. It is the 2nd highest ranked new release in the key US market on the platform, ahead of "The Walking Dead Road to Survival" and "Game of Thrones: Conquest" that both are games from major Hollywood franchises. This is a major validation of eRepublik Labs'

Reminder: C-RAD Web Presentation Interim Report Q3 2017

Date: Friday October 27, 2017 / kl. 11:00 Venue: Online Presentation Topic: C-RAD Interim Report Q3 2017 Procedure: Please register online through the website:   https://attendee.gotowebinar.com/register/5138153462507806466 After your registration, you will receive a confirmation via email. A recording of the presentation will be made accessible on the C-RAD website after the presentation.   About C-RAD C-RAD develops innovative solutions for use in advanced radiation therapy. The C-RAD group offers products and solutions for patient positioning, tumor

AZ and MSD rapidly advance Lynparza in Japan

23 October 2017 07:00 BST ASTRAZENECA AND MSD RAPIDLY ADVANCE LYNPARZA IN JAPAN WITH A SECOND REGULATORY SUBMISSION Potential to offer a new treatment option for patients withgermline BRCA-mutated, HER2-negative metastatic breast cancer   AstraZeneca and Merck & Co., Inc., Kenilworth, NJ, US (known as MSD outside the US and Canada) today announced that they have submitted a new drug application (NDA) to Japan's Pharmaceuticals and Medical Devices Agency (PMDA) for the use of Lynparza (olaparib) tablets in unresectable or recurrent BRCA-mutated breast cancer, with a decision

Responsibility begins at the level of management — but it is part of everyone's work

The chemical industry was a model student in acorporate responsibility study by FIBS . Corporate responsibility was deemed a material issue for the business in 90% of all chemical industry companies.Kiilto believes that responsibility includes three sectors: environment and product safety, personnel and working conditions, and sustainable business operations. Kiilto prepares responsibility reports in compliance with the GRI principles, but

Nepa helps Elkjøp to capture sales opportunities

The renowned home electronics retailer and one of the biggest media buyers in the Nordics, Elkjøp is relying heavily on their advertising investments to deliver ROI. Nepa has been entrusted to help Elkjøp drive more sales to their business by identifying and recommending strategic changes in their brand- and communication activities.The rapid digitization brings about a much more fragmented media consumption. Elkjøp has seen the need to better understand the changing and more fragmented media behavior among their consumers. “Nepa’s consumer science approach to identifying and executing

Etrion Announces Successful Purchase of EUR 6.3 Million of Its Corporate Bonds

October 23, 2017, Miami, Florida, United States – Etrion Corporation (“Etrion” or the “Company”) (TSX: ETX) (OMX: ETX), a solar independent power producer, announces today that it has purchased a nominal amount of approximately EUR 6.3 million of its outstanding corporate bonds (the “Bonds”) at par value, from certain existing bondholders. These Bonds will be held by the Company as an investment and will be reported as such in its financial statements.  Following this purchase of Bonds, the Company’s annual interest cost will be EUR 2.7MM ($3.2MM) per annum, a 17 % reduction from the

Altor enters partnership with the founders of RevolutionRace

On October 18th, Altor Fund IV (“Altor”) has signed an agreement to acquire a significant minority ownership in the fast growing Swedish consumer brand, RevolutionRace, from the founders Pernilla and Niclas Nyrensten. The founders will remain as majority owners of the company and continue in their operational roles as CEO and Head of Product.RevolutionRace sells outdoor apparel products through a direct to consumer model, with an innovative design, high quality & functionality at an affordable price point. The company was founded in 2013 and has grown at an impressive speed to a turnover of

US FDA approves Bydureon BCise for type-2 diabetes

23 October 2017 07:00 BST US FDA APPROVES NEW EASY-TO-USE, ONCE-WEEKLY BYDUREON BCISE INJECTABLE MEDICINE FOR PATIENTS WITH TYPE-2 DIABETES New formulation of once-weekly exenatide in an improved device provides significant HbA1c reduction with added benefit of weight loss AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved Bydureon BCise (exenatide extended-release) injectable suspension, a new formulation of Bydureon in an improved once-weekly, single-dose autoinjector device for adults with type-2 diabetes whose blood sugar remains

Skanska sells nursing home in Gothenburg, Sweden, for about SEK 240M

Skanska has sold a nursing home under construction in Gothenburg, Sweden, for about SEK 240 million. The buyer is property fund managed by Northern Horizon and Ambea will become the tenant. The transaction will be recorded by Skanska Commercial Property Development in the fourth quarter 2017. The transfer of the property is scheduled for the spring 2019, in connection with completion.The project comprises a retirement home with 72 apartments on five floors located in the center of Angered, Gothenburg. The nursing home of about 5,300 square meters has been developed by Skanska in cooperation

There are no items matching the current filter
There are no more items matching the current filter
Back to top